Abstract:
Objective By comparing with laparoscopic total mesorectal excision (La-TME), to analyze the clinical efficacy and safety of laparoscopic transanal total mesorectal excision (La-TaTME) in the treatment of ultra-low rectal cancer.
Methods From August 2015 to March 2018, 114 patients with ultra-low rectal cancer admitted to Wenjiang District People’s Hospital of Chengdu were randomly divided into La-TaTME group and La-TME group, each with 57 cases. The clinical indexes, PAC-QOL score, micturition function, complications and prognosis between the two groups were compared.
Results Compared with La-TME group, the operation time of La-TaTME group was longer, the anal exhaust time and hospitalization time were shorter, the differences were statistically significant (P< 0.05). At 12 months after operation, PAC-QOL scores of the two groups were significantly raised, and La-TaTME group was higher than La-TME group (P<0.05). There were no significant differences between the two groups in urination function, complication rate, 1-year survival rate, distant metastasis rate or local recurrence rate.
Conclusion The operation time of La-TaTME is longer than that of La-TME in the treatment of ultra-low rectal cancer, La-TaTME is more conducive to the early rehabilitation and quality of life of patients.
Key words:
Rectal neoplasms,
Colorectal surgery,
Ultra-low,
Total mesorectal resection,
Transanal,
Laparoscopy
Bo Wang. Laparoscopic assisted transanal total mesorectal excision in the treatment of ultra-low rectal cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(03): 226-229.